Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
Caristo Diagnostics has raised $150K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
Caristo Diagnostics's investors include Oxford Science Enterprises, Longwall Venture, BGF Ventures, Oxford University Innovation, HeartX.
Caristo Diagnostics is headquartered in Oxford, United Kingdom.
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
Caristo Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Caristo Diagnostics — Funding & Investors." VCBacked, September 30, 2024, https://www.vcbacked.co/company/caristo-diagnostics. Accessed November 12, 2026.
VCBacked. (2024). Caristo Diagnostics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/caristo-diagnostics
{{cite web |title=Caristo Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/caristo-diagnostics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Caristo Diagnostics? Request a listing update